Los puntos clave no están disponibles para este artículo en este momento.
The lung adenocarcinoma intrinsic molecular subtypes co-occur with grossly distinct genomic alterations and with patient therapy response. These results advance the understanding of lung adenocarcinoma etiology and nominate patient subgroups for future evaluation of treatment response.
Wilkerson et al. (Thu,) studied this question.